These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


90 related items for PubMed ID: 2456111

  • 1. The NK-3 tachykinin receptor agonist senktide elicits 5-HT-mediated behaviour following central or peripheral administration in mice and rats.
    Stoessl AJ, Dourish CT, Iversen SD.
    Br J Pharmacol; 1988 Jun; 94(2):285-7. PubMed ID: 2456111
    [Abstract] [Full Text] [Related]

  • 2. Senktide, a selective neurokinin B-like agonist, elicits serotonin-mediated behaviour following intracisternal administration in the mouse.
    Stoessl AJ, Dourish CT, Young SC, Williams BJ, Iversen SD, Iversen LL.
    Neurosci Lett; 1987 Oct 05; 80(3):321-6. PubMed ID: 2446214
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological characterization of the behavioural syndrome induced by the NK-3 tachykinin agonist senktide in rodents: evidence for mediation by endogenous 5-HT.
    Stoessl AJ, Dourish CT, Iversen SD.
    Brain Res; 1990 May 28; 517(1-2):111-6. PubMed ID: 1695859
    [Abstract] [Full Text] [Related]

  • 4. Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat.
    Cellier E, Barbot L, Regoli D, Couture R.
    Br J Pharmacol; 1997 Oct 28; 122(4):643-54. PubMed ID: 9375960
    [Abstract] [Full Text] [Related]

  • 5. The tachykinin NK3 receptor agonist senktide induces locomotor activity in male Mongolian gerbils.
    Nordquist RE, Durkin S, Jacquet A, Spooren W.
    Eur J Pharmacol; 2008 Dec 14; 600(1-3):87-92. PubMed ID: 18930726
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacological characterization of senktide-induced tail whips.
    Nordquist RE, Ballard TM, Algeyer B, Pauly-Evers M, Ozmen L, Spooren W.
    Neuropharmacology; 2010 Jan 14; 58(1):259-67. PubMed ID: 19540857
    [Abstract] [Full Text] [Related]

  • 10. Localization of Fos-like immunoreactivity induced by the NK3 tachykinin receptor agonist, senktide, in the guinea-pig brain.
    Yip J, Chahl LA.
    Br J Pharmacol; 1997 Oct 14; 122(4):715-25. PubMed ID: 9375969
    [Abstract] [Full Text] [Related]

  • 11. Behavioural effects of selective tachykinin agonists in midbrain dopamine regions.
    Stoessl AJ, Szczutkowski E, Glenn B, Watson I.
    Brain Res; 1991 Nov 29; 565(2):254-62. PubMed ID: 1668812
    [Abstract] [Full Text] [Related]

  • 12. Intranigral tachykinin NK3 receptor agonist elicits oral movements in rats.
    Liminga U, Johansson PE, Gunne L.
    Pharmacol Biochem Behav; 1991 Mar 29; 38(3):617-20. PubMed ID: 1712496
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Autoradiographic visualization of NK-3 tachykinin binding sites in the rat brain, utilizing [3H]senktide.
    Stoessl AJ, Hill DR.
    Brain Res; 1990 Nov 26; 534(1-2):1-7. PubMed ID: 1705846
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists.
    Sundqvist M, Kristensson E, Adolfsson R, Leffler A, Ahlstedt I, Engberg S, Drmota T, Sigfridsson K, Jussila R, de Verdier J, Novén A, Johansson A, Påhlman I, von Mentzer B, Lindström E.
    Eur J Pharmacol; 2007 Dec 22; 577(1-3):78-86. PubMed ID: 17920583
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The selective NK3 receptor agonist senktide excites a subpopulation of dopamine-sensitive neurones in the rat substantia nigra pars compacta in vitro.
    Keegan KD, Woodruff GN, Pinnock RD.
    Br J Pharmacol; 1992 Jan 22; 105(1):3-5. PubMed ID: 1375857
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.